Topical oral syrup prevents early childhood caries

July 5, 2008

Dental researchers at the University of Washington have reported a significant reduction of tooth decay in toddlers who were treated with the topical syrup xylitol, a naturally occurring non-cavity-causing sweetener. Their results were presented today during the 86th General Session of the International Association for Dental Research.

In a recent clinical trial in the Republic of the Marshall Islands, children 6 to 15 months old were given oral doses of xylitol in fruit-flavored syrup daily to determine whether the substance can prevent early-childhood tooth decay, or "caries".

Researchers reported that nearly 76% of the children in the group who received xylitol were free of tooth decay by the end of the study, compared with 48% of the children in the group that did not receive the substance.

The Marshall Islands in the Pacific were chosen for the study because it is an area where childhood tooth decay is a serious public health problem. The average child entering Head Start at age 5 has 6.8 cavities—two to three times the rate in a typical mainland community. Researchers came from the Northwest/Alaska Center to Reduce Oral Health Disparities and the Department of Dental Public Health Sciences at the University of Washington, Seattle.

Xylitol can be administered in the form of chewing gum, lozenges, or syrup. The U.S. Food and Drug Administration has approved xylitol's use in food since 1963 and classifies the substance as safe.

According to researchers, at the end of the trial nearly 76% of the children in the study group were caries-free, compared with 48% in a comparable group that did not receive treatment.

Xylitol is a five-carbon sugar alcohol that is used as a sugar substitute.

Source: International & American Association for Dental Research


print this article email this article download pdf blog this article bookmark this article     Stumble it Digg this share on Facebook retweet share on Reddit add to delicious
Rate this story - 4.2 /5 (5 votes)

Rank Filter

Move the slider to adjust rank threshold, so that you can hide some of the comments.


Display comments: newest first

  • sheber - Jul 06, 2008
    • Rank: not rated yet
    Children used for experimentation with chemical products who can't agree to the research for themselves. Poor things.

July 5, 2008 all stories

Comments: 1

4.2 /5 (5 votes)
  • Stumble this up

  • Digg this

  • share this

  • hide
  • Related Stories




  • hide
  • Relevant PhysicsForums posts

Other News

ISU psychologists offer parental advice on promoting kids' healthy video game play

ISU psychologists offer parental advice on promoting kids' healthy video game play

Medicine & Health / Psychology & Psychiatry

created 33 minutes ago | popularity not rated yet | comments 0

(PhysOrg.com) -- Parents often find themselves in a holiday quandary when deciding on which video games to purchase for their kids. They know that their children want video games, but they also want to ensure ...


Factors from common human bacteria may trigger multiple sclerosis

Medicine & Health / Diseases

created 33 minutes ago | popularity 5 / 5 (1) | comments 0

Current research suggests that a common oral bacterium may exacerbate autoimmune disease. The related report by Nichols et al, "Unique Lipids from a Common Human Bacterium Represent a New Class of TLR2 Ligands Capable of ...


Road rage: Fuel vapor heightens aggression

Medicine & Health / Research

created 41 minutes ago | popularity not rated yet | comments 0

Outrageous prices may not be the only thing causing anger at the petrol pumps. A new study, published in the open access journal BMC Physiology, has shown that rats exposed to fumes from leaded and unleaded gasoline become ...


Control of blood clotting by platelets described; provides medical promise

Medicine & Health / Research

created 3 minutes ago | popularity not rated yet | comments 0

Cell fragments called platelets are essential to promote blood clotting. Virginia Tech faculty members and students have discovered novel molecular interactions at the surface of platelets that control blood clotting.


Metobolomics uncovers key indicators of nonalcoholic fatty liver disease

Medicine & Health / Diseases

created 3 minutes ago | popularity not rated yet | comments 0

A recent metobolomics study by researchers from Virginia Commonwealth University Medical Center in Richmond found that impaired peroxisomal oxidation of polyunsaturated fatty acids (PUFA) is associated with the progression ...